NU 641 ADVANCED CLINICAL
PHARMACOLOGY COMPREHENSIVE
EXAM QUESTIONS AND ANSWERS AND
EXPLANATIONS | LATEST - REGIS
1. Which of the following describes the ‘First-Pass Effect’ in pharmacokinetics?
A. The excretion of drugs through the renal tubules during the first cycle of filtration.
B. The rapid uptake of drugs by the brain across the blood-brain barrier.
C. The metabolism of a drug by the liver before it reaches systemic circulation.
D. The initial binding of a drug to plasma albumin upon entering the bloodstream.
Answer: C
Conceptual Explanation: The first-pass effect occurs when an orally administered drug is
absorbed from the GI tract and carried to the liver via the portal vein, where it is
metabolized before reaching the systemic circulation, often reducing its bioavailability.
2. A patient taking Warfarin is prescribed Amiodarone for atrial fibrillation. What is the
expected interaction?
A. Amiodarone induces CYP2C9, decreasing Warfarin levels and increasing clot risk.
B. There is no significant interaction between these two medications.
C. Amiodarone increases renal clearance of Warfarin, requiring a higher dose.
,D. Amiodarone inhibits CYP2C9, increasing Warfarin levels and increasing bleeding risk.
Answer: D
Conceptual Explanation: Amiodarone is a potent inhibitor of CYP2C9, the primary
enzyme responsible for metabolizing S-warfarin. This inhibition leads to increased
warfarin concentrations and a significantly higher risk of bleeding; the warfarin dose
usually needs to be reduced by 30-50%.
3. Which mechanism explains the development of angioedema in patients taking ACE
inhibitors?
A. Direct stimulation of H1 receptors by the medication molecule.
B. Excessive suppression of Aldosterone leading to sodium wasting.
C. Increased levels of Bradykinin due to inhibition of Kininase II.
D. Inhibition of cyclooxygenase-2 leading to leukotriene shunting.
Answer: C
Conceptual Explanation: ACE (also known as Kininase II) is responsible for breaking
down Bradykinin. When ACE is inhibited, Bradykinin levels rise, which can cause
vasodilation and increased vascular permeability, resulting in angioedema.
4. In the management of Type 2 Diabetes, which class of medications primarily acts by
inhibiting the SGLT2 transporter in the kidneys?
A. Sulfonylureas
, B. Gliflozins
C. GLP-1 Agonists
D. DPP-4 Inhibitors
Answer: B
Conceptual Explanation: Sodium-glucose cotransporter 2 (SGLT2) inhibitors, commonly
known as gliflozins (e.g., Empagliflozin), lower blood glucose by preventing the
reabsorption of glucose in the proximal tubule, leading to glycosuria.
5. Which of the following is a characteristic feature of Zero-Order elimination kinetics?
A. A constant percentage of the drug is eliminated per unit of time.
B. The half-life of the drug remains constant regardless of the dose.
C. A constant amount of the drug is eliminated per unit of time.
D. Elimination is proportional to the plasma concentration of the drug.
Answer: C
Conceptual Explanation: In zero-order kinetics, the elimination rate is independent of
concentration because the metabolic pathways are saturated. A fixed amount (e.g.,
10mg/hour) is removed, unlike first-order where a fixed percentage is removed.
6. A 65-year-old male with chronic kidney disease (CKD) requires an antibiotic. Which of the
following is most likely to require significant dose adjustment based on GFR?
A. Ceftriaxone
PHARMACOLOGY COMPREHENSIVE
EXAM QUESTIONS AND ANSWERS AND
EXPLANATIONS | LATEST - REGIS
1. Which of the following describes the ‘First-Pass Effect’ in pharmacokinetics?
A. The excretion of drugs through the renal tubules during the first cycle of filtration.
B. The rapid uptake of drugs by the brain across the blood-brain barrier.
C. The metabolism of a drug by the liver before it reaches systemic circulation.
D. The initial binding of a drug to plasma albumin upon entering the bloodstream.
Answer: C
Conceptual Explanation: The first-pass effect occurs when an orally administered drug is
absorbed from the GI tract and carried to the liver via the portal vein, where it is
metabolized before reaching the systemic circulation, often reducing its bioavailability.
2. A patient taking Warfarin is prescribed Amiodarone for atrial fibrillation. What is the
expected interaction?
A. Amiodarone induces CYP2C9, decreasing Warfarin levels and increasing clot risk.
B. There is no significant interaction between these two medications.
C. Amiodarone increases renal clearance of Warfarin, requiring a higher dose.
,D. Amiodarone inhibits CYP2C9, increasing Warfarin levels and increasing bleeding risk.
Answer: D
Conceptual Explanation: Amiodarone is a potent inhibitor of CYP2C9, the primary
enzyme responsible for metabolizing S-warfarin. This inhibition leads to increased
warfarin concentrations and a significantly higher risk of bleeding; the warfarin dose
usually needs to be reduced by 30-50%.
3. Which mechanism explains the development of angioedema in patients taking ACE
inhibitors?
A. Direct stimulation of H1 receptors by the medication molecule.
B. Excessive suppression of Aldosterone leading to sodium wasting.
C. Increased levels of Bradykinin due to inhibition of Kininase II.
D. Inhibition of cyclooxygenase-2 leading to leukotriene shunting.
Answer: C
Conceptual Explanation: ACE (also known as Kininase II) is responsible for breaking
down Bradykinin. When ACE is inhibited, Bradykinin levels rise, which can cause
vasodilation and increased vascular permeability, resulting in angioedema.
4. In the management of Type 2 Diabetes, which class of medications primarily acts by
inhibiting the SGLT2 transporter in the kidneys?
A. Sulfonylureas
, B. Gliflozins
C. GLP-1 Agonists
D. DPP-4 Inhibitors
Answer: B
Conceptual Explanation: Sodium-glucose cotransporter 2 (SGLT2) inhibitors, commonly
known as gliflozins (e.g., Empagliflozin), lower blood glucose by preventing the
reabsorption of glucose in the proximal tubule, leading to glycosuria.
5. Which of the following is a characteristic feature of Zero-Order elimination kinetics?
A. A constant percentage of the drug is eliminated per unit of time.
B. The half-life of the drug remains constant regardless of the dose.
C. A constant amount of the drug is eliminated per unit of time.
D. Elimination is proportional to the plasma concentration of the drug.
Answer: C
Conceptual Explanation: In zero-order kinetics, the elimination rate is independent of
concentration because the metabolic pathways are saturated. A fixed amount (e.g.,
10mg/hour) is removed, unlike first-order where a fixed percentage is removed.
6. A 65-year-old male with chronic kidney disease (CKD) requires an antibiotic. Which of the
following is most likely to require significant dose adjustment based on GFR?
A. Ceftriaxone
